Off-label medicine use: Ethics, practice and future directions.

Area of Science:

• Pharmacology
• Medical Ethics
• Health Policy

Background:

• Off-label medicine use involves prescribing drugs for unapproved indications, dosages, routes, or patient groups.
• This practice is common across various therapeutic classes and patient demographics, frequently affecting vulnerable populations.

Purpose of the Study:

• To discuss ethical, practical, and policy considerations surrounding off-label medicine use.
• To highlight the importance of informed consent and risk-benefit discussions in off-label prescribing.

Main Methods:

• Literature review and synthesis of current guidelines and ethical frameworks.
• Analysis of professional organization recommendations on off-label prescribing.

Main Results:

• Professional organizations recommend informing patients about off-label use, documenting consent, and discussing potential risks and benefits.
• Prescribers must document the rationale for off-label prescribing and ensure patient awareness of duration and monitoring.

Conclusions:

• Addressing off-label medicine use requires collaborative efforts from all stakeholders, including consumers, to promote Quality Use of Medicine and Medicine Safety.
• Clear guidelines and transparent communication are essential for mitigating risks associated with off-label prescribing.